View source for 6hvh


==Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 1==
<StructureSection load='6hvh' size='340' side='right' caption='[[6hvh]], [[Resolution|resolution]] 2.36&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[6hvh]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HVH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6HVH FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=F6P:FRUCTOSE-6-PHOSPHATE'>F6P</scene>, <scene name='pdbligand=FLC:CITRATE+ANION'>FLC</scene>, <scene name='pdbligand=GV2:3-[[8-(1-methylindol-6-yl)quinoxalin-6-yl]amino]-~{N}-(oxan-4-yl)pyridine-4-carboxamide'>GV2</scene>, <scene name='pdbligand=POP:PYROPHOSPHATE+2-'>POP</scene></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PFKFB3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6hvh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hvh OCA], [http://pdbe.org/6hvh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6hvh RCSB], [http://www.ebi.ac.uk/pdbsum/6hvh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6hvh ProSAT]</span></td></tr>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/F263_HUMAN F263_HUMAN]] Synthesis and degradation of fructose 2,6-bisphosphate. 
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Energy and biomass production in cancer cell is largely supported by aerobic glycolysis in what is called the "Warburg effect". The process is regulated by key enzymes among which phosphofructokinase PFK-2 plays a significant role by producing fructose-2,6-biphosphate, the most potent activator of the glycolysis rate limiting step performed by phosphofructokinase PFK-1. We report herein the synthesis, biological evaluation and structure-activity relationship of novel inhibitors of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), the ubiquitous and hypoxia-induced isoform of PFK-2. X-Ray crystallography and docking were instrumental in the design and optimization of a N-aryl 6-aminoquinoxaline series. The most potent representative, compound 69, displayed a 14 nM IC50 on target, and a 0.49 muM IC50 of fructose-2,6-biphosphate production in human colon carcinoma HCT116 cells. This work provides a new entry in the field of PFKFB3 inhibitors with potential for development in oncology.

Discovery and Structure-Activity Relationships of N-Aryl 6-Aminoquinoxalines as Potent PFKFB3 Kinase Inhibitors.,Boutard N, Bialas A, Sabiniarz A, Guzik P, Banaszak K, Biela A, Bien M, Buda A, Bugaj B, Cieluch E, Cierpich A, Dudek L, Eggenweiler HM, Fogt J, Gaik M, Gondela A, Jakubiec K, Jurzak M, Kitlinska A, Kowalczyk P, Kujawa M, Kwiecinska K, Les M, Lindemann R, Maciuszek M, Mikulski M, Niedziejko P, Obara A, Pawlik H, Rzymski T, Sieprawska-Lupa M, Sowinska M, Szeremeta-Spisak J, Stachowicz A, Tomczyk MM, Wiklik K, Ziemianska S, Wloszczak L, Zarebski A, Brzozka K, Nowak M, Fabritius CH ChemMedChem. 2018 Oct 30. doi: 10.1002/cmdc.201800569. PMID:30378281<ref>PMID:30378281</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 6hvh" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Human]]
[[Category: Banaszak, K]]
[[Category: Bialas, A]]
[[Category: Fabritius, C H]]
[[Category: Jakubiec, K]]
[[Category: Nowak, M]]
[[Category: Cancer]]
[[Category: Complex]]
[[Category: Kinase]]
[[Category: Metabolism]]
[[Category: Transferase]]